Afatinib Overcomes Osimertinib Resistance via Egfr V804F Mutation in a Syngeneic Egfr-Mutant Lung Cancer Mouse Model.
- DOI
- 10.1111/cas.70431
- Published
- 2026 Sep
- Container
- Cancer science
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1111/cas.70431,
title = {Afatinib Overcomes Osimertinib Resistance via Egfr V804F Mutation in a Syngeneic Egfr-Mutant Lung Cancer Mouse Model.},
author = {Tanaka T and Fujitani M and Taoka M and Shimomura I and Okawa S and Mori S and Kuribayashi T and Nishimura J and Nishimura T and Morita A and Hara N and Ninomiya K and Makimoto G and Higo H and Rai K and Ichihara E and Tomida S and Hotta K and Togashi Y and Maeda Y and Kiura K and Katayama R and Ohashi K},
year = {2026},
journal = {Cancer science},
doi = {10.1111/cas.70431},
url = {https://doi.org/10.1111/cas.70431}
}RIS
TY - JOUR TI - Afatinib Overcomes Osimertinib Resistance via Egfr V804F Mutation in a Syngeneic Egfr-Mutant Lung Cancer Mouse Model. AU - Tanaka T AU - Fujitani M AU - Taoka M AU - Shimomura I AU - Okawa S AU - Mori S AU - Kuribayashi T AU - Nishimura J AU - Nishimura T AU - Morita A AU - Hara N AU - Ninomiya K AU - Makimoto G AU - Higo H AU - Rai K AU - Ichihara E AU - Tomida S AU - Hotta K AU - Togashi Y AU - Maeda Y AU - Kiura K AU - Katayama R AU - Ohashi K PY - 2026 JO - Cancer science DO - 10.1111/cas.70431 UR - https://doi.org/10.1111/cas.70431 ER -
APA
T, T., M, F., M, T., I, S., S, O., S, M., T, K., J, N., T, N., A, M., N, H., K, N., G, M., H, H., K, R., E, I., S, T., K, H., Y, T., Y, M., K, K., R, K., & K, O. (2026). Afatinib Overcomes Osimertinib Resistance via Egfr V804F Mutation in a Syngeneic Egfr-Mutant Lung Cancer Mouse Model.. Cancer science. https://doi.org/10.1111/cas.70431
Source records
- pubmed · retrieved 2026-09-25T02:30:34.907Z